Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 1159981-95-9 | MDL No. : | MFCD11042744 |
Formula : | C6H4BrN3 | Boiling Point : | No data available |
Linear Structure Formula : | - | InChI Key : | DIYTVASYDOBYQA-UHFFFAOYSA-N |
M.W : | 198.02 | Pubchem ID : | 45480508 |
Synonyms : |
|
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
49% | With potassium phosphate; tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; water; at 90℃; for 4.0h;Inert atmosphere; | To a solution of <strong>[1159981-95-9]5-bromopyrazolo[1,5-a]pyrimidine</strong> (300 mg, 1.5 mmol) in 1,4-dioxane (10 mL) and water (2 mL), were sequentially added 4-ethoxycarbonyl phenyl boronic acid (380 mg, 1.95 mmol), K3PO4 (955 mg, 4.5 mmol) and Pd(PPh3)4 (52 mg, 0.04 mmol). The reaction mixture was heated at 90° C. for 4 h under argon atmosphere then, was diluted with EtOAc and washed with water and brine solution. The organic layer was dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography (silica gel, eluent petroleumether/EtOAc 9:1 to 1:1) to afford ethyl 4-(pyrazolo[1,5-a]pyrimidin-5-yl)benzoate (200 mg, 49percent) of as a yellow solid. 1H NMR (400 MHz, CDCl3) delta (ppm): 8.77 (d, J=8.0, 1H), 8.18-8.15 (m, 4H), 7.33 (d, J=7.5 Hz, 2H), 7.12 (d, J=4.4 Hz, 1H), 6.77 (d, J=2.2 Hz, 1H), 4.45 (q, J=6.8 Hz, 2H), 1.44 (t, J=7.2 Hz, 3H); MS (ESI) m/z 268 [C15H13N3O2+H]+. |
[ 705263-10-1 ]
6-Bromopyrazolo[1,5-a]pyrimidine
Similarity: 0.80
[ 55405-67-9 ]
3-Bromopyrazolo[1,5-a]pyrimidine
Similarity: 0.78
[ 1211578-31-2 ]
6-Bromo-3-methylpyrazolo[1,5-a]pyrimidine
Similarity: 0.77
[ 1436686-17-7 ]
Ethyl 5-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate
Similarity: 0.69
[ 934560-92-6 ]
6-Bromo-1H-pyrazolo[3,4-b]pyridine
Similarity: 0.69
[ 705263-10-1 ]
6-Bromopyrazolo[1,5-a]pyrimidine
Similarity: 0.80
[ 55405-67-9 ]
3-Bromopyrazolo[1,5-a]pyrimidine
Similarity: 0.78
[ 1211578-31-2 ]
6-Bromo-3-methylpyrazolo[1,5-a]pyrimidine
Similarity: 0.77
[ 232600-93-0 ]
3-Aminopyrazolo[1,5-a]pyrimidine
Similarity: 0.74